Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 201 | $29,462,377 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 07 Mar 2025 16:16 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 05 Mar 2025 | Sale | 20,000 | 6.58 | 131,600 | D |
| 07 Mar 2025 16:16 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Mar 2025 | Sale | 20,000 | 6.37 | 127,400 | D |
| 07 Feb 2025 16:14 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 05 Feb 2025 | Sale | 20,000 | 7.68 | 153,600 | D |
| 07 Feb 2025 16:14 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Feb 2025 | Sale | 20,000 | 8.12 | 162,400 | D |
| 13 Jan 2025 17:26 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 08 Jan 2025 | Sale | 20,000 | 7.31 | 146,200 | D |
| 13 Jan 2025 17:26 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 10 Jan 2025 | Sale | 20,000 | 7.05 | 141,000 | D |
| 06 Dec 2024 17:46 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 04 Dec 2024 | Sale | 20,000 | 7.16 | 143,200 | D |
| 06 Dec 2024 17:46 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 05 Dec 2024 | Sale | 20,000 | 7.12 | 142,400 | D |
| 15 Nov 2024 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 13 Nov 2024 | Sale | 20,000 | 7.74 | 154,800 | D |
| 15 Nov 2024 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 14 Nov 2024 | Sale | 20,000 | 7.35 | 147,000 | D |
| 14 Nov 2024 19:19 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 12 Nov 2024 | Sale | 11,447 | 7.6402 | 87,457 | D |
| 14 Nov 2024 19:19 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 12 Nov 2024 | Sale | 15,000 | 7.6419 | 114,628 | D |
| 14 Nov 2024 19:19 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 13 Nov 2024 | Sale | 15,000 | 7.6584 | 114,876 | D |
| 31 Oct 2024 18:01 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 29 Oct 2024 | Sale | 11,447 | 6.7202 | 76,926 | D |
| 28 Oct 2024 17:25 | RXRX | RECURSION PHARMACEUTICALS Inc | MARRIOTT TINA | President and COO | 24 Oct 2024 | Sale | 6,000 | 6.3091 | 37,855 | D |
| 17 Oct 2024 17:27 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 15 Oct 2024 | Sale | 11,447 | 6.6678 | 76,326 | D |
| 10 Oct 2024 18:40 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 08 Oct 2024 | Sale | 15,000 | 6.3171 | 94,756 | D |
| 10 Oct 2024 18:40 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 09 Oct 2024 | Sale | 15,000 | 6.3583 | 95,374 | D |
| 04 Oct 2024 18:30 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 Oct 2024 | Sale | 20,000 | 6.16 | 123,200 | D |
| 04 Oct 2024 18:30 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Oct 2024 | Sale | 20,000 | 6.08 | 121,600 | D |
| 03 Oct 2024 16:58 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 01 Oct 2024 | Sale | 11,447 | 6.2156 | 71,150 | D |
| 30 Sep 2024 18:15 | RXRX | RECURSION PHARMACEUTICALS Inc | MARRIOTT TINA | President and COO | 26 Sep 2024 | Sale | 6,000 | 7.0008 | 42,005 | D |
| 19 Sep 2024 17:48 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 17 Sep 2024 | Sale | 11,447 | 6.8431 | 78,333 | D |
| 12 Sep 2024 18:28 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 11 Sep 2024 | Sale | 15,000 | 6.3153 | 94,730 | D |
| 12 Sep 2024 18:28 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 10 Sep 2024 | Sale | 15,000 | 6.1666 | 92,499 | D |
| 06 Sep 2024 16:57 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 05 Sep 2024 | Sale | 20,000 | 6.14 | 122,800 | D |
| 06 Sep 2024 16:57 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 04 Sep 2024 | Sale | 20,000 | 6.04 | 120,800 | D |
| 05 Sep 2024 17:25 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 03 Sep 2024 | Sale | 11,447 | 6.2652 | 71,718 | D |
| 03 Sep 2024 16:48 | RXRX | RECURSION PHARMACEUTICALS Inc | MARRIOTT TINA | President and COO | 29 Aug 2024 | Sale | 6,000 | 7.5627 | 45,376 | D |
| 22 Aug 2024 18:48 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 20 Aug 2024 | Sale | 11,447 | 7.1226 | 81,532 | D |
| 15 Aug 2024 17:24 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 14 Aug 2024 | Sale | 15,000 | 6.3501 | 95,252 | D |
| 15 Aug 2024 17:24 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 13 Aug 2024 | Sale | 15,000 | 6.3455 | 95,182 | D |
| 09 Aug 2024 16:56 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 08 Aug 2024 | Sale | 20,000 | 6.5 | 130,000 | D |
| 09 Aug 2024 16:56 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 07 Aug 2024 | Sale | 30,000 | 7.1 | 213,000 | D |
| 08 Aug 2024 17:23 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 06 Aug 2024 | Sale | 11,447 | 6.8213 | 78,083 | D |
| 29 Jul 2024 18:16 | RXRX | RECURSION PHARMACEUTICALS Inc | MARRIOTT TINA | President and COO | 25 Jul 2024 | Sale | 6,000 | 8.1349 | 48,809 | D |
| 25 Jul 2024 18:15 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 23 Jul 2024 | Sale | 11,447 | 8.4774 | 97,041 | D |
| 12 Jul 2024 18:54 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 11 Jul 2024 | Sale | 50,000 | 7.47 | 373,500 | D |
| 12 Jul 2024 18:54 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 10 Jul 2024 | Sale | 50,000 | 7.48 | 374,000 | D |
| 11 Jul 2024 16:51 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 09 Jul 2024 | Sale | 15,000 | 7.3185 | 109,778 | D |
| 11 Jul 2024 16:51 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 10 Jul 2024 | Sale | 15,000 | 7.2384 | 108,576 | D |
| 11 Jul 2024 16:51 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 09 Jul 2024 | Sale | 11,447 | 7.315 | 83,735 | D |
| 28 Jun 2024 17:14 | RXRX | RECURSION PHARMACEUTICALS Inc | MARRIOTT TINA | President and COO | 27 Jun 2024 | Sale | 6,000 | 7.215 | 43,290 | D |
| 27 Jun 2024 19:13 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 25 Jun 2024 | Sale | 11,447 | 9.5052 | 108,806 | D |
| 17 Jun 2024 17:46 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 14 Jun 2024 | Sale | 15,000 | 9.2721 | 139,082 | D |
| 17 Jun 2024 17:46 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 13 Jun 2024 | Sale | 15,000 | 9.3199 | 139,798 | D |
| 13 Jun 2024 17:36 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 11 Jun 2024 | Sale | 11,447 | 8.4531 | 96,763 | D |
| 07 Jun 2024 16:01 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Jun 2024 | Sale | 50,000 | 9 | 450,000 | D |
| 07 Jun 2024 16:01 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 05 Jun 2024 | Sale | 50,000 | 8.42 | 421,000 | D |
| 03 Jun 2024 18:31 | RXRX | RECURSION PHARMACEUTICALS Inc | MARRIOTT TINA | President and COO | 30 May 2024 | Sale | 3,000 | 8.775 | 26,325 | D |
| 30 May 2024 18:41 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 28 May 2024 | Sale | 11,447 | 9.1677 | 104,943 | D |
| 16 May 2024 16:35 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 14 May 2024 | Sale | 20,054 | 10.1194 | 202,934 | D |
| 03 May 2024 18:24 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 May 2024 | Sale | 28,704 | 8.47 | 243,123 | D |
| 03 May 2024 18:24 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 May 2024 | Sale | 21,296 | 8.47 | 180,377 | D |
| 03 May 2024 18:24 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 01 May 2024 | Sale | 50,000 | 7.73 | 386,500 | D |
| 02 May 2024 17:41 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 30 Apr 2024 | Sale | 11,447 | 7.9465 | 90,964 | D |
| 29 Apr 2024 18:41 | RXRX | RECURSION PHARMACEUTICALS Inc | MARRIOTT TINA | President and COO | 25 Apr 2024 | Sale | 3,000 | 7.6735 | 23,020 | D |
| 18 Apr 2024 17:12 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 16 Apr 2024 | Sale | 11,447 | 7.6636 | 87,725 | D |
| 18 Apr 2024 17:12 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 17 Apr 2024 | Sale | 23,124 | 7.583 | 175,349 | D |
| 18 Apr 2024 17:12 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 16 Apr 2024 | Sale | 25,000 | 7.6663 | 191,658 | D |
| 05 Apr 2024 17:44 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 04 Apr 2024 | Sale | 25,000 | 9.02 | 225,500 | I |
| 05 Apr 2024 17:44 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Apr 2024 | Sale | 25,000 | 8.84 | 221,000 | I |
| 05 Apr 2024 17:44 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 04 Apr 2024 | Sale | 40,000 | 9.02 | 360,800 | D |
| 05 Apr 2024 17:44 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Apr 2024 | Sale | 40,000 | 8.84 | 353,600 | D |
| 03 Apr 2024 17:42 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 02 Apr 2024 | Sale | 11,447 | 8.8182 | 100,942 | D |
| 01 Apr 2024 18:40 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 28 Mar 2024 | Sale | 25,000 | 10.1 | 252,500 | I |
| 01 Apr 2024 18:40 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 28 Mar 2024 | Sale | 40,000 | 10.1 | 404,000 | D |
| 25 Mar 2024 18:39 | RXRX | RECURSION PHARMACEUTICALS Inc | MARRIOTT TINA | President and COO | 21 Mar 2024 | Sale | 610 | 11.3361 | 6,915 | D |
| 25 Mar 2024 18:39 | RXRX | RECURSION PHARMACEUTICALS Inc | MARRIOTT TINA | President and COO | 21 Mar 2024 | Sale | 7,390 | 10.6989 | 79,065 | D |
| 21 Mar 2024 17:38 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 19 Mar 2024 | Sale | 20,054 | 10.792 | 216,423 | D |
| 14 Mar 2024 19:28 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 13 Mar 2024 | Sale | 25,000 | 11.0326 | 275,815 | D |
| 14 Mar 2024 19:28 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 12 Mar 2024 | Sale | 25,000 | 10.455 | 261,375 | D |
| 08 Mar 2024 19:08 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Mar 2024 | Sale | 1,000 | 11.5621 | 11,562 | I |
| 08 Mar 2024 19:08 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Mar 2024 | Sale | 20,000 | 11.5501 | 231,002 | I |
| 08 Mar 2024 19:08 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Mar 2024 | Sale | 4,000 | 11.5648 | 46,259 | I |
| 08 Mar 2024 19:08 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Mar 2024 | Sale | 36,319 | 11.8583 | 430,682 | D |
| 07 Mar 2024 18:53 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 05 Mar 2024 | Sale | 20,054 | 12.0577 | 241,805 | D |
| 23 Feb 2024 19:22 | RXRX | RECURSION PHARMACEUTICALS Inc | MARRIOTT TINA | President and COO | 22 Feb 2024 | Sale | 8,000 | 14.895 | 119,160 | D |
| 21 Feb 2024 17:37 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 20 Feb 2024 | Sale | 19,745 | 12.3117 | 243,095 | D |
| 21 Feb 2024 17:37 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 20 Feb 2024 | Sale | 309 | 13.0432 | 4,030 | D |
| 15 Feb 2024 18:00 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 14 Feb 2024 | Sale | 1,067 | 10.9841 | 11,720 | D |
| 15 Feb 2024 18:00 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 14 Feb 2024 | Sale | 23,933 | 10.4335 | 249,705 | D |
| 15 Feb 2024 18:00 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 13 Feb 2024 | Sale | 25,000 | 9.8624 | 246,560 | D |
| 09 Feb 2024 17:34 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 07 Feb 2024 | Sale | 48,272 | 9.2182 | 444,981 | D |
| 08 Feb 2024 18:54 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 06 Feb 2024 | Sale | 11,447 | 9.3028 | 106,489 | D |
| 29 Jan 2024 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 25 Jan 2024 | Sale | 8,000 | 10.3452 | 82,762 | D |
| 25 Jan 2024 18:13 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 23 Jan 2024 | Sale | 20,054 | 10.5756 | 212,083 | D |
| 18 Jan 2024 18:39 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 16 Jan 2024 | Sale | 18,000 | 10.93 | 196,740 | D |
| 18 Jan 2024 18:37 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 17 Jan 2024 | Sale | 25,000 | 10.2539 | 256,348 | D |
| 18 Jan 2024 18:37 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 16 Jan 2024 | Sale | 25,000 | 10.4464 | 261,160 | D |
| 11 Jan 2024 18:51 | RXRX | RECURSION PHARMACEUTICALS Inc | LI DEAN Y | Director | 09 Jan 2024 | Sale | 28,038 | 13.65 | 382,719 | I |
| 11 Jan 2024 18:51 | RXRX | RECURSION PHARMACEUTICALS Inc | LI DEAN Y | Director | 09 Jan 2024 | Sale | 962 | 14.0282 | 13,495 | I |
| 11 Jan 2024 18:50 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 09 Jan 2024 | Sale | 6,303 | 13.2124 | 83,278 | D |
| 11 Jan 2024 18:50 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 09 Jan 2024 | Sale | 13,751 | 13.8117 | 189,925 | D |
| 05 Jan 2024 20:03 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Jan 2024 | Sale | 1,000 | 9.4939 | 9,494 | I |
| 05 Jan 2024 20:03 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Jan 2024 | Sale | 20,000 | 9.512 | 190,240 | I |
| 05 Jan 2024 20:03 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Jan 2024 | Sale | 4,000 | 9.5073 | 38,029 | I |
| 05 Jan 2024 20:03 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Jan 2024 | Sale | 30,853 | 9.4903 | 292,804 | D |
| 02 Jan 2024 16:58 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 28 Dec 2023 | Sale | 8,000 | 10.5817 | 84,654 | D |
| 28 Dec 2023 17:48 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 26 Dec 2023 | Sale | 20,054 | 10.6285 | 213,144 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)